Vitamin D-do our patients need not just a room with a view, but one with sunshine?
M. Murray
DOI: https://doi.org/10.1097/CCM.0000000000000258
IF: 8.8
2014-06-01
Critical Care Medicine
Abstract:1540 www.ccmjournal.org June 2014 • Volume 42 • Number 6 Vitamin D comes in two forms, D2 (ergocalciferol) and D3 (cholecalciferol), that have the same chemical structure except that D 2 has a methyl group on Carbon 24 of the parent molecule. D 2 is ingested in foods whereas D 3 can be synthesized in the skin from the action of ultraviolet light on 7-dehydrocholesterol. Both compounds are metabolically inert. The active compound is the product of two chemical reactions—the first occurs in the liver mediated by 25-hydroxylase which forms 25-hydroxyvitamin D or 25OHD, and the second in the kidney where 1α-hydroxylase converts 25OHD to the biologically active hormone 1,25(OH) 2 vitamin D (calcitriol), active in the regulation of serum calcium and phosphate levels. 25OHD is carried in the bloodstream by vitamin D binding protein (DBP). Following its synthesis in the kidney, 1,25(OH) 2 , calcitriol, is transported to its sites of action by the same DBP. Even though calcitriol is the biologically active molecule, most studies of the effects of vitamin D have measured its precursor, 25OHD. Other than an additional methyl group on Carbon 24 there is no known difference between 25OHD derived from ergocalciferol (25OH vitamin D 2 ) or from cholecalciferol (25OH vitamin D 3 ), and therefore, these observational studies focus on total 25OHD levels. 25OHD bound to DBP circulates in the blood and when calcium levels decrease, or for other unknown reasons, the 25OHD is taken up by the kidney and hydroxylated to the biologically active calcitriol. The process is tightly controlled and calcitriol is not produced in the kidney unless there is a need. The traditional view of calcitriol being the biologically active form of vitamin D and 25OHD being a prohormone has been challenged by recent experiments in knockout mice deficient in 1α-hydroxylase. Although some studies have shown that such animals develop rickets, it is possible to provide sufficient dietary calcium to normalize serum calcium levels (1) not just due to the enhanced calcium intake but presumably due to the action of 25OHD. Calcitriol exerts its effects when investigations, it will be important to more clearly delineate when and how the inflammasome develops and if similar findings occur in other traumatic injuries or even in the face of hyperglycemia from other mechanisms. If induction of an inflammasome was due to mediators or DAMPs from the burn injury, then one might reasonably expect lower degrees of activation and less persistence if burns are excised early. Another unanswered question is whether widespread inflammasomes might be responsible for dysfunction of other organ systems in ICU patients—for example, altered mental status (10) or renal function (11). The authors made an observation that may be relevant in this regard, but they were unable to tease it apart in the current investigation. They observed that the control subjects, those undergoing elective plastic or reconstructive procedures, also had monocytes (CD45+) and neutrophils (CD11+) within their adipose tissue. Importantly, this cellular infiltration was seen within the timeframe of their operative intervention, suggesting that relatively minor trauma leads to rapid innate immune cell infiltration into otherwise normal tissue. In the current study, only uninjured fat tissue was examined, so in future studies, it would also be important to see if innate immune cells are also present in liver, renal, lung, or other tissues. REFERENCES 1. Levy MM, Fink MP, Marshall JC, et al; SCCM/ESICM/ACCP/ATS/ SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250–1256 2. Zhang Q, Raoof M, Chen Y, et al: Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464:104–107 3. Piccinini AM, Midwood KS: DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010; 2010:672395 4. Stanojcic M, Chen P, Harrison RA, et al: Leukocyte Infiltration and Activation of the NLRP3 Inflammasome in White Adipose Tissue Following Thermal Injury. Crit Care Med 2014; 42:1357–1364 5. Martinon F, Burns K, Tschopp J: The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10:417–426 6. Xiao W, Mindrinos MN, Seok J, et al; and the Inflammation and Host Response to Injury Large-Scale Collaborative Research Program: A genomic storm: Reprioritization of the human leukocyte transcriptome in the critically injured patient. J Exp Med 2011; 208:2581–2590 7. Xu H, Barnes GT, Yang Q, et al: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112:1821–1830 8. Schäffler A, Schölmerich J: Innate immunity and adipose tissue biology. Trends Immunol 2010; 31:228–235 9. Stienstra R, Tack CJ, Kanneganti TD, et al: The inflammasome puts obesity in the danger zone. Cell Metab 2012; 15:10–18 10. Walsh JG, Muruve DA, Power C: Inflammasomes in the CNS. Nat Rev Neurosci 2014; 15:84–97 11. Anders HJ, Muruve DA: The inflammasomes in kidney disease. J Am Soc Nephrol 2011; 22:1007–1018